Stock-Based Compensation (Tables)

3 Months Ended

Mar. 31, 2023

Stock-Based Compensation

Schedule of stock based compensation expense categories in statement of operations

	Three months ended March 31,
	2023		2022
Sales and marketing	$	401	$	307
General and administrative		554		464
Research and development		173		130
Total stock‑based compensation	$	1,128	$	901

Schedule of stock option activity

				Weighted
				average
		Weighted		remaining
	Number of	average exercise		contractual term
	shares	price per share		(years)
Outstanding at January 1, 2023	2,071,848		11.49
Granted	180,800		10.53
Exercised	(9,922)		4.44
Canceled/forfeited	(20,302)		11.77
Outstanding at March 31, 2023	2,222,424	$	11.44	7.12
Vested and expected to vest at March 31, 2023	2,165,187	$	11.44	7.07
Exercisable at March 31, 2023	1,354,140	$	11.34	6.07

Schedule of weighted average assumptions

	Three months ended
	March 31, 2023
Expected dividend yield	—
Expected volatility	73.6	%
Risk‑free interest rate	4.04	%
Expected term (in years)	6.26

Schedule of restricted stock units (RSUs)

	Number of
	shares
Unvested balance at January 1, 2023	311,991
Granted	520,858
Vested	(78,666)
Canceled/forfeited	(2,075)
Outstanding at March 31, 2023	752,108